IL2 and neoplasm: The emergence of patient-derived organoids (PDO) offers a physiologically relevant ex vivo platform for functionally evaluating TIL by preserving tumor heterogeneity.<h4>Methods</h4>TIL were isolated from BCa patient specimens and robustly expanded ex vivo using interleukin-2 (IL-2) and a rapid expansion protocol (REP).